<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0220">
 <label>44</label>
 <element-citation publication-type="journal" id="rf0215">
  <person-group person-group-type="author">
   <name>
    <surname>Wu</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>X.O.</given-names>
   </name>
  </person-group>
  <article-title>TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib [published online ahead of print, 2020 Mar 11]</article-title>
  <source>J Microbiol Immunol Infect.</source>
  <volume>53</volume>
  <issue>3</issue>
  <year>2020</year>
  <fpage>368</fpage>
  <lpage>370</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jmii.2020.03.005</pub-id>
  <pub-id pub-id-type="pmid">32205092</pub-id>
 </element-citation>
</ref>
